Non-Invasive Aav9-Mediated Silencing of Mutant Ataxin-3 Alleviates Motor and Neuropathological Deficits in a Transgenic Mouse Model of Machado-Joseph Disease
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Date: OCT 18-21, 2016, Location: Florence, ITALY, Sponsors: Int Soc Stem Cell Res, Assoc Biologia Cellulare & Differenziamento
